NOV Downgraded at Citi as EBITDA Could Struggle to Grow in 2025
NOV Cut to Neutral From Buy by Citigroup
Citi Downgrades NOV Inc(NOV.US) to Hold Rating, Cuts Target Price to $18
NOV Is Maintained at Underweight by Wells Fargo
NOV Analyst Ratings
Wells Fargo Maintains NOV Inc(NOV.US) With Sell Rating, Cuts Target Price to $15
J.P. Morgan Maintains NOV Inc(NOV.US) With Buy Rating, Cuts Target Price to $20
NOV Price Target Cut to $21.00/Share From $22.00 by Susquehanna
NOV Is Maintained at Buy by Stifel
NOV Analyst Ratings
Stifel Maintains Buy on NOV, Lowers Price Target to $24
A Quick Look at Today's Ratings for NOV Inc(NOV.US), With a Forecast Between $21 to $25
NOV (NOV) Receives a Hold From RBC Capital
Benchmark Co. Maintains NOV Inc(NOV.US) With Hold Rating
Seaport Global Maintains NOV Inc(NOV.US) With Buy Rating, Maintains Target Price $21
Evercore Maintains NOV Inc(NOV.US) With Buy Rating, Maintains Target Price $27
A Quick Look at Today's Ratings for NOV Inc(NOV.US), With a Forecast Between $21 to $28
Morgan Stanley Maintains NOV Inc(NOV.US) With Buy Rating, Maintains Target Price $23
NOV (NOV) Gets a Buy From Morgan Stanley
NOV Price Target Cut to $17.00/Share From $20.00 by Barclays